Creating computer models to improve inhalers for lung diseases
Computational Fluid Dynamics (CFD) Models to Aid the Development of Generic Metered Dose Inhalers
This study is working on new computer models to make generic inhalers better at delivering medicine to your lungs for conditions like asthma and COPD, so that patients can get the most out of their inhalers.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Commonwealth University NIH-funded |
| Lab location | 1 site (Richmond, United States) |
| Project ID | NIH-11146794 on NIH RePORTER |
What this research studies
This research focuses on developing advanced computer models to enhance the effectiveness of generic inhalers used for treating lung diseases like asthma and COPD. By using computational fluid dynamics (CFD), the team aims to predict how well medication from these inhalers reaches different parts of the lungs. The project involves creating open-source software that simulates the behavior of inhaled drugs, which will help establish better correlations between laboratory tests and actual drug delivery in patients. This approach seeks to overcome current challenges in getting generic inhalers approved by the FDA.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with asthma or chronic obstructive pulmonary disease (COPD) who use inhalers for their treatment.
Not a fit: Patients who do not use inhalers or have lung diseases that do not require inhaled medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more affordable and effective inhalers, improving treatment adherence and outcomes for patients with lung diseases.
How similar studies have performed: Other research has shown promise in using computational models for drug delivery, indicating that this approach could be effective in improving inhaler design.
Where this research is happening
Richmond, United States
- Virginia Commonwealth University — Richmond, United States (Active)
Researchers
- Principal investigator: Longest, P. Worth — Virginia Commonwealth University
- Study coordinator: Longest, P. Worth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.